{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:23:05Z","timestamp":1787509385876,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:p>\n                    Thrombopoietin (TPO) is the critical regulator of platelet production. However, the role of TPO in pediatric patients with thrombocytopenic disorders has not been fully elucidated. In the present study, we attempted to investigate serum TPO levels in patients with acquired aplastic anemia (aAA) and immune thrombocytopenia (ITP). We analyzed the endogenous plasma concentration of TPO and platelet count at the time of TPO measurement in 166 patients with aAA and 280 patients with ITP retrospectively. We further observed a correlation between platelet counts and TPO. Serum TPO levels were significantly higher in aAA compared with ITP (1142 vs. 77.99\u00a0pg\/mL,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001). In patients with aAA, an elevation for TPO levels in very severe AA (VSAA) was seen when compared with non-severe AA (NSAA) (1360 vs. 984.4\u00a0pg\/mL,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.05). In contrast, the circulating TPO levels with chronic ITP (CITP) showed a decrease than newly diagnosed ITP (NITP) and persistent ITP (PITP) (62.28 vs. 81.56\u00a0pg\/mL,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.01, 62.28 vs. 87.82\u00a0pg\/mL,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.05, respectively). There was a negative correlation between platelet counts and TPO levels in aAA (r\n                    <jats:sub>s<\/jats:sub>\n                    =\u22120.3325,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001) as well as ITP (r\n                    <jats:sub>s<\/jats:sub>\n                    =\u22120.2570,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001). Especially, TPO levels were inversely correlated with platelet counts in NSAA (r\n                    <jats:sub>s<\/jats:sub>\n                    =\u22120.3672,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001) and NITP (r\n                    <jats:sub>s<\/jats:sub>\n                    =\u22120.3316,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001). After grouping by age or sex, there were no statistical differences in aAA or ITP. Serum TPO levels were markedly elevated in pediatric patients with aAA compared with ITP. It was higher in VSAA and lower in CITP, suggesting that serum TPO level could play a role in classifying disease severity or clinical course in aAA and ITP.\n                  <\/jats:p>","DOI":"10.1097\/mph.0000000000002873","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T13:06:05Z","timestamp":1718024765000},"page":"281-286","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["The Differences of Serum Thrombopoietin Levels Between Acquired Aplastic Anemia and Immune Thrombocytopenia in Pediatric Patients"],"prefix":"10.1097","volume":"46","author":[{"given":"Hui","family":"Chen","sequence":"first","affiliation":[{"name":"Hematologic Disease Laboratory, Hematology Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[{"name":"Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology; National Key Discipline of Pediatrics (Capital Medical University); Key Laboratory of Major Diseases in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntao","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Hematologic Disease Laboratory, Hematology Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Fu","sequence":"additional","affiliation":[{"name":"Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology; National Key Discipline of Pediatrics (Capital Medical University); Key Laboratory of Major Diseases in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Ma","sequence":"additional","affiliation":[{"name":"Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology; National Key Discipline of Pediatrics (Capital Medical University); Key Laboratory of Major Diseases in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Yao","sequence":"additional","affiliation":[{"name":"Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology; National Key Discipline of Pediatrics (Capital Medical University); Key Laboratory of Major Diseases in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhui","family":"Wu","sequence":"additional","affiliation":[{"name":"Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology; National Key Discipline of Pediatrics (Capital Medical University); Key Laboratory of Major Diseases in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenping","family":"Chen","sequence":"additional","affiliation":[{"name":"Hematologic Disease Laboratory, Hematology Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V86.2.419.bloodjournal862419","article-title":"Thrombopoietin: the primary regulator of platelet production","volume":"86","author":"Kaushansky","year":"1995","journal-title":"Blood"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/blood.V86.1.54.bloodjournal86154","article-title":"Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates","volume":"86","author":"Farese","year":"1995","journal-title":"Blood"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI26674","article-title":"The molecular mechanisms that control thrombopoiesis","volume":"115","author":"Kaushansky","year":"2005","journal-title":"J Clin Investig"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood.V85.10.2720.bloodjournal85102720","article-title":"The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit","volume":"85","author":"Kuter","year":"1995","journal-title":"Blood"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/pbc.25885","article-title":"The highs and lows of measuring thrombopoietin in aplastic anemia","volume":"63","author":"Corey","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2141.1996.d01-1966.x","article-title":"Serum thrombopoietin levels in patients with aplastic anaemia","volume":"95","author":"Marsh","year":"1996","journal-title":"Br J Haematol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1111\/j.1538-7836.2006.02091.x","article-title":"Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi-center prospective study","volume":"4","author":"Kuwana","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2141.1996.d01-1702.x","article-title":"Circulating thrombopoietin level in chronic immune thrombocytopenic purpura","volume":"93","author":"Kosugi","year":"1996","journal-title":"Br J Haematol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.hoc.2018.03.001","article-title":"The pathophysiology of acquired aplastic anemia: current concepts revisited","volume":"32","author":"Schoettler","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young","year":"2018","journal-title":"New Engl J Med"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/diagnostics12020313","article-title":"Development of an automated chemiluminescent enzyme immunoassay for measuring thrombopoietin in human plasma","volume":"12","author":"Nishikawa","year":"2022","journal-title":"Diagnostics"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N Engl J Med"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12185-013-1370-4","article-title":"Pathophysiology and management of primary immune thrombocytopenia","volume":"98","author":"Kashiwagi","year":"2013","journal-title":"Int J Hematol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1309\/RAW2-0LQW-8YTX-941V","article-title":"Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia","volume":"115","author":"Kurata","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/0973-6247.150956","article-title":"Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity","volume":"9","author":"Singh","year":"2015","journal-title":"Asian J Transf Sci"},{"key":"R16-20250804","first-page":"983","article-title":"Plasma thrombopoietin levels in patients with aplastic anemia and idiopathic thrombocytopenic purpura","volume":"115","author":"Gu","year":"2002","journal-title":"Chinese Med J-Peking"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2141.1998.00590.x","article-title":"Thrombopoietin serum levels in patients with aplastic anaemia: correlation with platelet count and persistent elevation in remission","volume":"100","author":"Schrezenmeier","year":"1998","journal-title":"Br J Haematol"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br J Haematol"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood.V48.1.63.63","article-title":"Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality","volume":"48","author":"Camitta","year":"1976","journal-title":"Blood"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2141.1988.tb02460.x","article-title":"Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party","volume":"70","author":"Bacigalupo","year":"1988","journal-title":"Br J Haematol"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ped4.12305","article-title":"Adapted guideline for the diagnosis and treatment of primary immune thrombocytopenia for Chinese children (2021)","volume":"6","year":"2022","journal-title":"Pediatr Invest"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, defnitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/pbc.25820","article-title":"Markedly high plasma thrombopoietin (TPO) Level is a predictor of poor response to immunosuppressive therapy in children with acquired severe aplastic anemia","volume":"63","author":"Elmahdi","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1182\/blood.V87.10.4068.bloodjournal87104068","article-title":"Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction","volume":"87","author":"Emmons","year":"1996","journal-title":"Blood"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1365-2141.1996.d01-1741.x","article-title":"A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders","volume":"93","author":"Tahara","year":"1996","journal-title":"Br J Haematol"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s002770050538","article-title":"Serum levels of thrombopoietin, IL-11, and IL-6 in pediatric thrombocytopenias","volume":"78","author":"Cremer","year":"1999","journal-title":"Ann Hematol"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1055\/s-0038-1656057","article-title":"Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis","volume":"77","author":"Nagata","year":"1997","journal-title":"Thromb Haemost"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.V86.3.971.971","article-title":"Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice","volume":"86","author":"Ulich","year":"1995","journal-title":"Blood"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1182\/blood.V92.6.2189","article-title":"Primary role of the liver in thrombopoietin production shown by tissue-specific knockout","volume":"92","author":"Qian","year":"1998","journal-title":"Blood"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1182\/blood.V95.10.3094","article-title":"The role of platelet alpha-granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells","volume":"95","author":"Sungaran","year":"2000","journal-title":"Blood"},{"key":"R32-20250804","first-page":"365a","article-title":"Human platelets as a model for the binding, intemalization, and degradation of thrombopoietin (TPO)","volume":"86","author":"Fielder","year":"1995","journal-title":"Blood"},{"key":"R33-20250804","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2001-15251","article-title":"Thrombopoietin in thrombocytopenias of childhood","volume":"27","author":"Dame","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"R34-20250804","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1365-2141.1997.992915.x","article-title":"Measurement of endogenous thrombopoietin in patients with acquired aplastic anaemia by a sensitive enzyme linked immunosorbent assay","volume":"97","author":"Kojima","year":"1997","journal-title":"Br J Haematol"},{"key":"R35-20250804","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1365-2141.1998.00683.x","article-title":"Serum thrombopoietin level is mainly regulated by megakaryocyte mass rather than platelet mass in human subjects","volume":"101","author":"Nagasawa","year":"1998","journal-title":"Br J Haematol"},{"key":"R36-20250804","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood.V92.1.46.413k44_46_52","article-title":"Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells","volume":"92","author":"Hirayama","year":"1998","journal-title":"Blood"},{"key":"R37-20250804","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/ajh.23562","article-title":"Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists.","volume":"88","author":"Makar","year":"2013","journal-title":"Am J Hematol"},{"key":"R38-20250804","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1634\/theoncologist.1-1-98","article-title":"Thrombopoietin: Biology and clinical applications","volume":"1","author":"Kuter","year":"1996","journal-title":"Oncologist"},{"key":"R39-20250804","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000362531","article-title":"Relationships of mean platelet volume and plasma thrombopoietin with glycocalicin levels in thrombocytopenic patients","volume":"133","author":"Khaspekova","year":"2015","journal-title":"Acta Haematol"},{"key":"R40-20250804","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","article-title":"Thrombopoietin receptor agonists: ten years later","volume":"104","author":"Ghanima","year":"2019","journal-title":"Haematologica"},{"key":"R41-20250804","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/S2352-3026(15)00114-3","article-title":"Eltrombopag for the treatment of children with Persistent and Chronic Immune Thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study","volume":"2","author":"Bussel","year":"2015","journal-title":"Lancet Haematol"},{"key":"R42-20250804","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/2040620712442525","article-title":"Eltrombopag, a thrombopoietinreceptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile","volume":"3","author":"Cheng","year":"2012","journal-title":"Ther Adv Hematol"},{"key":"R43-20250804","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2040620717693573","article-title":"From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag","volume":"8","author":"Gill","year":"2017","journal-title":"Ther Adv Hematol"},{"key":"R44-20250804","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s12185-017-2275-4","article-title":"Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice","volume":"106","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Int J Hematol"},{"key":"R45-20250804","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","article-title":"Eltrombopag added to standard immunosuppression for aplastic anemia","volume":"376","author":"Townsley","year":"2017","journal-title":"N Engl J Med"},{"key":"R46-20250804","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/bjh.17403","article-title":"Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries","volume":"194","author":"Scheinberg","year":"2021","journal-title":"Br J Haematol"},{"key":"R47-20250804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2040620721998126","article-title":"Current evidence and the emerging role of eltrombopag in severe aplastic anemia","volume":"12","author":"Drexler","year":"2021","journal-title":"Ther Adv Hematol"},{"key":"R48-20250804","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/08880018.2021.1900475","article-title":"Efficacy and safety of eltrombopag in the first-line therapy of severe aplastic anemia in children","volume":"38","author":"J Ma","year":"2021","journal-title":"Pediatr Hemat Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:05:20Z","timestamp":1754337920000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002873","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,10]]},"assertion":[{"value":"2024-01-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}